...
首页> 外文期刊>Revista de Gastroenterolog??a de M??xico >Primary intestinal lymphangiectasia: twenty years of experience at a Mexican tertiary care hospital
【24h】

Primary intestinal lymphangiectasia: twenty years of experience at a Mexican tertiary care hospital

机译:原发性肠淋巴管扩张症:在墨西哥三级医院的二十年经验

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Primary intestinal lymphangiectasia is a rare congenital disease described by Waldmann in 1961 that is a consequence of obstruction of the lymphatic drainage of the small bowel with secondary lymph vessel dilation. This distorts the architecture of the villi and causes a leakage of lymph into the intestinal lumen, resulting in protein-losing enteropathy and malabsorption. Aim To describe the clinical, biochemical, radiologic, endoscopic, and histologic characteristics in children with primary intestinal lymphangiectasia. Method A retrospective observational, descriptive, cross-sectional study was conducted that reviewed the case records of children diagnosed with primary intestinal lymphangiectasia that were seen at the Department of Gastroenterology and Nutrition of the Instituto Nacional de Pediatría within the time frame of January 1, 1992 to September 30, 2012. Results Four patients were found that presented with primary intestinal lymphangiectasia. Three of them had been diagnosed before 3 years of age. All the patients presented with chronic diarrhea, edema, lymphopenia, hypocalcemia, and hypogammaglobulinemia, and 3 patients presented with hypocholesterolemia. Bowel transit time, endoscopy, and intestinal biopsies were characteristic of this pathology. Conclusions Intestinal lymphangiectasia should be suspected when there is a clinical picture of chronic diarrhea and protein-losing enteropathy accompanied with edema at any level, as well as hypoalbuminemia, hypocalcemia, lymphopenia, hypogammaglobulinemia, and hypocholesterolemia, which are the main biochemical findings of this pathology. All children presenting with intestinal lymphangiectasia should undergo an upper gastrointestinal series with bowel transit time and endoscopy with biopsies taken at the level of the duodenum. Treatment includes diet and the periodic administration of albumin and gamma globulin.
机译:背景技术原发性肠淋巴管扩张症是Waldmann在1961年描述的一种罕见的先天性疾病,是小肠淋巴引流受阻,继发性淋巴管扩张导致的。这扭曲了绒毛的结构,并导致淋巴漏入肠腔,导致蛋白质丢失性肠病和吸收不良。目的描述儿童原发性肠淋巴管扩张的临床,生化,影像学,内镜和组织学特征。方法回顾性观察性描述性横断面研究进行了回顾性研究,回顾了1992年1月1日在国立儿科研究所胃肠与营养学系发现的被诊断患有原发性肠淋巴管扩张的儿童的病例记录。至2012年9月30日。结果发现四名患者出现原发性肠淋巴管扩张。其中三名在3岁之前被诊断出。所有患者均表现为慢性腹泻,水肿,淋巴细胞减少,低血钙和低血球蛋白血症,3例表现为低胆固醇血症。肠运输时间,内窥镜检查和肠道活检是这种病理学的特征。结论当临床表现为慢性腹泻和蛋白丢失性肠病伴有任何水平的水肿以及低白蛋白血症,低钙血症,淋巴减少症,低血球蛋白血症和低胆固醇血症时,应怀疑肠道小肠淋巴管扩张症。 。所有表现为肠淋巴管扩张的儿童均应进行上消化道系列检查,包括肠运输时间和内窥镜检查,并在十二指肠水平进行活检。治疗方法包括饮食和定期服用白蛋白和丙种球蛋白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号